dr bennett's semaglutide Dr. John Bennett, MD Unveiling the Therapeutic Potential of

In a randomized, single-blind, 24-week study, participants assigned to dual therapy of 2 mg weekly of the GLP-1 receptor agonist exenatide (Bydureon, AstraZeneca) and 10 mg daily of the SGLT2 inhibitor dapagliflozin (Farxiga, AstraZeneca) lost more weight than those taking either agent alone or those receiving dapagliflozin and metformin extended-release (Xigduo XL, AstraZeneca) or phentermine/topiramate extended-release (Qsymia, Vivus)

Compounded versions are prepared by 503A pharmacies under individualized prescription, which allows more flexible dosing, useful when a patient needs a dose between standard pen strengths or has specific clinical needs the branded product cannot accommodate

Documentation and handling notes Documentation Regenerative peptide listings should be reviewed alongside the pack size, vial format, stock status, and any available product documentation before ordering

GLP-1s were also tied to lower risks for preterm and cesarean births

These effects can leave you feeling fuller for longer and less hungry than usual, which can lead to reduced caloric intake and ultimately promote weight loss